v3.25.2
Schedule of financial information represents the amount in the financial statements (Details) - USD ($)
11 Months Ended 12 Months Ended
Feb. 06, 2024
Mar. 31, 2025
Mar. 31, 2025
Mar. 31, 2024
Jun. 30, 2025
Dec. 31, 2024
Dec. 31, 2023
IfrsStatementLineItems [Line Items]              
Current assets   $ 1 $ 1        
Loss for the financial year   18,503          
Total liabilities   (18,503) (18,503)        
Revenue for the financial year            
(Loss)/Profit for the financial year   (18,503)          
TOTAL ASSETS   3,615,387 3,615,387   $ 3,797,033 $ 3,699,990 $ 28,872,916
Total liabilities   (10,875,855) (10,875,855)   $ (14,571,784) $ (11,162,750) $ (8,197,948)
Alps Life Science Inc [Member]              
IfrsStatementLineItems [Line Items]              
Current assets   1,490,968 1,490,968 $ 1,284,502      
Current liabilities   (7,489,747) (7,489,747) (5,055,579)      
Loss for the financial year     2,624,738 2,391,161      
Non-current assets   5,642,669 5,642,669 5,416,431      
Total assets   7,133,637 7,133,637 6,700,933      
Non-current liabilities   (759,806) (759,806) (194,362)      
Total liabilities   (8,249,553) (8,249,553) (5,249,941)      
Revenue for the financial year     3,371,037 2,403,552      
(Loss)/Profit for the financial year     (2,624,738) (2,391,161)      
Exchange differences   99,432 $ 99,432 $ (860)      
Vax Biotech Sdn Bhd [member] | Alps Life Science Inc [Member]              
IfrsStatementLineItems [Line Items]              
Place of incorporation     Malaysia        
Effective equity interest     30.00% 30.00%      
Principal activities     Manufacture of medicaments        
Current assets   732 $ 732 $ 686      
Current liabilities   (2,725) (2,725) (2,596)      
Net liabilities of the associate   (1,993) (1,993) (1,910)      
Expenses for the financial year     (1,183) (1,147)      
Loss for the financial year     (1,183) (1,147)      
Share of loss of the associate     (355) (344)      
(Loss)/Profit for the financial year     1,183 1,147      
Proportion of net assets of the associate   (671) (671) (657)      
Exchange differences   73 73 84      
Carrying amount of the Group’s interest in associate   (598) $ (598) $ (573)      
Alps Globemedics Sdn Bhd [member] | Alps Life Science Inc [Member]              
IfrsStatementLineItems [Line Items]              
Place of incorporation     Malaysia        
Effective equity interest     30.00% 30.00%      
Principal activities     Marketing of health and beauty product and services        
Current assets   36,502 $ 36,502 $ 28,413      
Current liabilities   (16,483) (16,483) (14,263)      
Loss for the financial year     (7,375) 16,893      
Non-current assets   3,529 3,529 3,377      
Total assets   40,031 40,031 31,790      
Non-current liabilities   (759)      
Total liabilities   (16,483) (16,483) (15,022)      
Net assets of the associate   23,548 23,548 16,768      
Revenue for the financial year     187,465 120,942      
(Loss)/Profit for the financial year     7,375 (16,893)      
Share of (loss)/profit of the associate     2,213 (5,068)      
Proportion of net assets of the associate   7,421 7,421 5,652      
Exchange differences   (357) (357) (622)      
Carrying amount of the Group’s interest in associate   7,064 $ 7,064 $ 5,030      
Cilo Cybin Holdings Limited [member] | Alps Life Science Inc [Member]              
IfrsStatementLineItems [Line Items]              
Place of incorporation     South Africa        
Effective equity interest 40.50%   40.50% 40.50%      
Principal activities     Investment in biotech, biohacking and pharmaceutical businesses        
Current assets   3,139,920 $ 3,139,920 $ 3,354,690      
Current liabilities   (114,958) (114,958) (593,538)      
Loss for the financial year     31,156 (21,809)      
Non-current liabilities   (173,968) (173,968)      
Net assets of the associate   3,049,852 3,049,852 2,761,152      
Revenue for the financial year     256,858 229,058      
(Loss)/Profit for the financial year     (31,156) 21,809      
Share of (loss)/profit of the associate     (12,618) 8,833      
Non-current assets   198,858 198,858      
TOTAL ASSETS   3,338,778 3,338,778 3,354,690      
Total liabilities   (288,926) (288,926) (593,538)      
Proportion of net assets of the associate   1,135,474 1,135,474 1,118,421      
Exchange differences   99,716 99,716 (154)      
Carrying amount of the Group’s interest in associate   $ 1,235,190 $ 1,235,190 $ 1,118,267